Edition:
United States

Prana Biotechnology Ltd (PRAN.OQ)

PRAN.OQ on NASDAQ Stock Exchange Capital Market

2.54USD
3:59pm EST
Change (% chg)

$0.03 (+1.20%)
Prev Close
$2.51
Open
$2.49
Day's High
$2.54
Day's Low
$2.47
Volume
3,965
Avg. Vol
11,191
52-wk High
$6.66
52-wk Low
$1.59

PRAN.OQ

Chart for PRAN.OQ

About

Prana Biotechnology Limited is a development-stage medical biotechnology company. The Company is engaged in the research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain focusing on Alzheimer's disease, Huntington disease, Parkinson's disease and other neurological... (more)
No analyst recommendations are available for PRAN.OQ.

Overall

Beta: 0.14
Market Cap(Mil.): $21.85
Shares Outstanding(Mil.): 8.90
Dividend: --
Yield (%): --

Financials

  PRAN.OQ Industry Sector
P/E (TTM): -- 44.03 29.85
EPS (TTM): -3.95 -- --
ROI: -21.93 -1.39 14.85
ROE: -21.93 -1.05 16.28

BRIEF-Prana Biotechnology Ltd provides regulatory update for PBT2

* Prana Biotechnology Ltd - further advice from US Food and Drug Administration (FDA) on steps necessary to remove Partial Clinical Hold (PCH) on PBT2

Nov 03 2016

BRIEF-Prana Biotechnology announces A$4.8 million R&D refund

* Asx alert-prana announces $4.8 million research and development refund-pbt.ax

Oct 30 2016

Earnings vs. Estimates